Skip to main content
Fig. 2 | Trials

Fig. 2

From: Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study

Fig. 2

Schedule of enrolment, interventions, and assessments. PCV13 (PV), 13-valent pneumococcal conjugate vaccine; 3+0, standard schedule of three primary doses; 1+1, alternative schedule of one primary dose and one booster dose; YF, yellow fever vaccine; NPS, nasopharyngeal swab; IgG, serotype-specific anti-pneumococcal type G immunoglobulin; OPA, serotype-specific opsonophagocytic activity; YFA, yellow fever neutralising antibody

Back to article page

Trials

ISSN: 1745-6215